Then, the knockdown of CDK5 decreased the protein expression levels of PES1 but not mRNA levels in pancreatic cancer cells (Fig. 6g and h), consistent with the results obtained after Dinaciclib treatment (Fig. 6c and d). The gene discussed is PES1; the disease is pancreatic neoplasm.